Optibiotix
Contact
  • facebook
  • linkedin
  • Store
  • Home
  • Technology
  • Products
  • Corporate
  • Investors
  • Media
  • News
  • Blog
  • Store
  • Contact

Investor Media

18th January 2022|Investor Media, News

Paul Cannings appointed Head of Operations & Quality at OptiBiotix

read more
Half year sales
22nd October 2021|Investor Media, News

OptiBiotix leads sector with surging half year interim sales figures

read more
12th April 2021|Investor Media, News

OptiBiotix Health announces René Kamminga as CEO of its subsidiary OptiBiotix Ltd

read more
Stephen Hammond MP
3rd March 2021|Investor Media, News

OptiBiotix Health Plc Announces New Non-Executive Director

read more
6th January 2021|Investor Media, News

Optibiotix Health Plc Announces New Company Director

read more
18th November 2020|Investor Media, News

Probiotix Health Announces Further Product Commercialisation Progress

read more
21st July 2020|Investor Media, News

ProBiotix Health Announces Major APAC Distribution Deal with Actial Farmaceutica for CholBiome®

read more
8th July 2020|Investor Media, News

Optibiotix announces major uk distribution deal with Cambridge Commodities Ltd

read more
1st June 2020|Investor Media, News

OptiBiotix announces three major deals with partners in US and Asia

read more
18th March 2020|Investor Media, News

OptiBiotix partners with Prosperous Pharma to bring SlimBiome® Medical to the Middle East

read more
Next

Categories

  • Blogs
  • Commercial Media
  • Investor Media
  • News
  • Partner Q&A
  • Scientific Media
  • Uncategorized

Recent Posts

  • Launch of products on Amazon India
  • Directorate change
  • CNBC Interview: Dr Morepen CEO forecasts £17m – £27m in 5 years with SlimBiome® containing Lightlife
  • Launch of Dr Morepen LightLife in India
  • Commercial update
OptiBiotix

Copyright © 2025. All rights reserved.    design by phd

  • Policies & Terms
  • Sitemap